0001203311-23-000106.txt : 20230901 0001203311-23-000106.hdr.sgml : 20230901 20230901165126 ACCESSION NUMBER: 0001203311-23-000106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230831 FILED AS OF DATE: 20230901 DATE AS OF CHANGE: 20230901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HIMES VAUGHN B CENTRAL INDEX KEY: 0001361966 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 231233194 MAIL ADDRESS: STREET 1: C/O SEATTLE GENETICS, INC. STREET 2: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2023-08-31 0 0001060736 Seagen Inc. SGEN 0001361966 HIMES VAUGHN B 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 Chief Technical Officer 0 Common Stock 2023-08-31 4 S 0 1795 206.9659 D 51439 D Common Stock 119471 I by Trust The sales reported in this Form 4 were effected pursuant to a written plan adopted on 11/21/2019 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. By: /s/ Jennifer Prosba For: Vaughn B Himes 2023-09-01